Hypophosphatemia induced in mice by transplantation of a tumor-derived cell line from a patient with oncogenic rickets

Journal of Pediatric Endocrinology and Metabolism

Volumn 9, Issue 6, 1996, Pages 593-597

  Chalew, Stuart A ^a,b   Lovchik, Judith C ^a   Brown, Caren M ^a   Sun, Chen Chih J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

Athymic mice; Cultured cells; hemangiopericytoma; Hypophosphatemia; Rickets; Transplantation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GRAFT; CASE REPORT; CHILD; HEMANGIOPERICYTOMA; HUMAN; HUMAN CELL; HYPOPHOSPHATEMIA; MALE; MOUSE; NONHUMAN; PATHOLOGY; RICKETS;

EID: 0030469460     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1996.9.6.593     Document Type: Article

References (13)

1. Ryan EA, Reiss E. Oncogenous osteomalacia: Review of the world literature of 42 cases and report of two new cases. Am J Med 1984; 77: 501-12.
2. Drezner MK. Tumor-associated rickets and osteomalacia. In: Favus MJ, ed, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 2nd Edition. New York: Raven Press, 1993; 282-288.
3. Hanukoglu A, Chalew SA, Sun CJ, Dorfman HD, Bright RW. Surgically curable rickets: Diagnosis and management. Clin Pediatr 1989; 28: 321-325.
4. Nuovo MA, Dorfman HD, Sun CJ, Chalew SA. Tumor-induced osteomalacia and rickets. Am J Surg Pathol 1989; 13: 588-599.
5. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-589.
6. Dryer RI, Tamnes AR, Routh JL. The determination of phosphorus and phosphate with N-phenyl-p-phenylenediamine. J Biol Chem 1957; 222: 177.
7. Taylor-Papadimitriou J, Purkis P, Lane EB, McKay IA, Chang SE. Effects of SV40 transformation on the cytoskeleton and behavioral properties of human keratinocytes. Cell Differentiation 1982; 11: 169-180.
8. Aschinberg LC, Solomon LM, Zeis PM, Justice P, Rosenthal IM. Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions. J Pediatr 1977; 91: 56-60.
9. Miyauchi A, Fukase M, Tsutsumi M, Fujita T. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25 hydroxyvitamin D-1-hydroxylase activity. J Clin Endocrinol Metab 1988; 67: 46-53.
10. Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R. Brief report: Inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia N Engl J Med 1994; 330: 1645-1649.
11. Wilkins GE, Granleese S, Hegele RG, Holdern J, Anderson DW, Bondy GP. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab 1995; 80: 1628-1634.
12. Taylor CR. Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist. Chapter 13, Immunohistology of the skin: Melanoma, intermediate filament. Philadelphia, PA: W.B. Saunders, 1986; 293.
13. O'Connor DT. Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum. Regul Pept 1983; 6: 263-280.